Minnesota Gov. Signs Law Streamlining Medical and Adult-Use Cannabis Supply Chains
- Minnesota Gov. Tim Walz signed a law streamlining the state's medical and adult-use cannabis supply chains.
- The law removes the combined medical and adult-use cannabis license, sets a 38,000 sq. ft. cap for indoor cultivation, and reserves 60,000 sq. ft. for medical cannabis, while introducing a cannabis microbusiness license starting in 2027.
- The legislation permits companies to hold both hemp and cannabis business licenses, aiming to create a more competitive market and address previous regulatory challenges.
- The Office of Cannabis Management must conduct a feasibility study on a therapeutic psilocybin program, with a report due by January 15, 2027.
Minnesota Gov. Tim Walz (D) last week signed into law legislation streamlining the state’s medical and adult-use cannabis supply chains.
The law eliminates the state’s current combination medical and adult-use cannabis license, sets a new plant canopy cap of 38,000 square feet for indoor cultivation – down from the maximum of 90,000 square feet for combination licenses – with 60,000 square feet reserved for medical cannabis products. The bill also creates a new cannabis microbusiness license in turn, which will be available starting in 2027.
Additionally, the legislation allows companies to hold both hemp and cannabis business licenses. In a statement, state Rep. Nolan West (R) called the previous regulations “absolutely brutal” for businesses and that the bill would fix “the litany of problems” in the state’s cannabis market and open it up so the state “can have a thriving market that isn’t dominated by just a few players.”
Additionally, the legislation requires the Office of Cannabis Management to develop a feasibility study to explore a therapeutic psilocybin program. The report for that study is due by January 15, 2027.